Beatty P G, Kollman C, Howe C W
The University of Utah, Salt Lake City, USA.
Clin Transpl. 1995:271-7.
As of January 1996, more than 4,000 marrow transplants have been performed using unrelated donors provided by the NMDP. With more than 1.9 million donors listed in the registry, over 70% of patients now find an HLA-A, -B, -DR phenotypic match at the initial search. The success rate is dramatically lower for patients in racial minorities. For instance, African-Americans find donors only 34% of the time on the initial search. Analysis of the first 462 transplants, showed disease-free survival rates at 2 years to be approximately 40% in low-risk patients, and 20% in high-risk patients. A more recent analysis in single centers shows an increase in the probabilities to 60-70%. This increase in success is likely related to a number of factors, including the ability to control complications, such as GVHD, plus an increase in accuracy of HLA typing primarily based on DNA-based methodology.
截至1996年1月,使用国家骨髓捐赠计划(NMDP)提供的非亲属捐赠者进行的骨髓移植已超过4000例。登记册中有超过190万名捐赠者,现在超过70%的患者在初次搜索时就能找到HLA - A、- B、- DR表型匹配的捐赠者。少数族裔患者的成功率则显著较低。例如,非裔美国人在初次搜索时找到捐赠者的几率仅为34%。对最初462例移植的分析表明,低风险患者2年无病生存率约为40%,高风险患者为20%。最近单中心的分析显示,这一概率已增至60% - 70%。成功率的提高可能与多种因素有关,包括控制移植物抗宿主病(GVHD)等并发症的能力,以及主要基于DNA方法的HLA分型准确性的提高。